Dr. Phillip Smiraldo, Ph.D., DABT
Medical Research Scientist
Dr. Smiraldo's timeless experience in the medical device industry encompasses toxicology, biological safety and preclinical study design, and includes extensive preparation of biological and toxicological risk assessments for submission in countries complying with EU and US FDA regulations. Prior to his current position as Toxicologist, he was a Medical Research Scientist and Study Director (NAMSA} overseeing special / custom preclinical functional studies, preclinical safety studies and simulated-use chemistry studies). Prior to joining NAMSA, Dr. Smiraldo was a Staff Toxicologist at WIL Research (approximately 2.5 years), where he was a Study Director of preclinical safety studies for pharmaceutical- and chemical-based products. He holds a PhD in Molecular and Cellular Biology from the University of Toledo Medical Center (formerly Medical College of Ohio) and a BS in Biology from Bowling Green State University (summa cum laude; with minors in Chemistry and Italian Language). He was a Postdoctoral Fellow at the University of Texas Southwestern Medical Center (awarded two grants to support his research), authored several articles that were published in peer-reviewed journals (regarding his research of DNA repair in mammalian cells), and authored a book chapter appearing in Telomerases: Chemistry, Biology, and Clinical Applications.
- GLOBAL REGULATORY REQUIREMENTS FOR CHEMICAL CHARACTERIZATION: HOW TO COST-EFFECTIVELY DEMONSTRATE BIOLOGICAL SAFETY - Hosted by NAMSA | Tue. February 5 - 9:10 AM - 9:50 AM
- Panel Discussion - Hosted by NAMSA | Tue. February 5 - 11:15 AM - 11:45 AM